Propanc Biopharma prices $4M stock offering

1 hour ago 1

Propanc Biopharma (OTCPK:PPCB) priced a public offering of 1M shares at $4 each, expecting $4M in gross proceeds to fund working capital and general purposes.
In connection with the offering, the company has also granted the underwriter a 45-day option to purchase up to 150,000 additional shares of common stock.
The company also received approval to list its common stock on the Nasdaq Capital Market, with trading set to start on August 15, 2025.

Recommended For You